Institute for Precision Cardiovascular Medicine
In 2013, the American Heart Association Board of Directors made a commitment to advance precision cardiovascular medicine. The initial platform launched as the Cardiovascular Genome-Phenome Study (CVGPS) before it evolved into the AHA Institute for Precision Cardiovascular Medicine.
Since 2015, the Institute has established innovative research models, formed strategic collaborations, and enabled patient engagement, data integration and access through state of-the-art technology. Today, the AHA is poised to play a crucial role in helping to deliver on the AHA mission and long-term value proposition.
The Institute is led by an Institute Executive Committee, a highly-diversified team of experts in the fields of genomics, bioinformatics, marketing, and start-up business.
Chief Executive Officer
Joseph Loscalzo, M.D., Ph.D.
Committee Person, Institute for Precision Cardiovascular Medicine Chairman, Department of Medicine Brigham and Women’s Hospital
Elliott Antman, M.D.
Professor of Medicine, Harvard Medical School Director, Harvard Postgraduate Education Program, Clinical and Translational Science Senior Faculty, Cardiovascular Division Brigham and Women’s Hospital
Ivor Benjamin, M.D., F.A.H.A., F.A.C.C.
Director-Cardiovascular Center Chief- Division of Cardiovascular Medicine Vice Chair- Translational Research Froedtert & Medical College of Wisconsin
Gregory L. Burke, M.D., M.Sc.
Professor and Chair, Division of Public Health Sciences Wake Forest University School of Medicine
Robert Harrington, M.D.
Arthur L. Bloomfield Professor of Medicine & Chair, Department of Medicine Stanford University
Steven Houser, Ph.D., FAHA
Chairman of the Department of Physiology Temple University School of Medicine
Daniel Jones, M.D.
Interim Chair, Department of Medicine Director, Clinical & Population Science Mississippi Center for Obesity Research University of Mississippi Medical Center
Senior Vice President of Population Health and Value-Based Care Novant Healthcare
Jennifer Hall, Ph.D., FAHA
Chief, Institute for Precision Cardiovascular Medicine American Heart Association
Rose Marie Robertson, M.D., FAHA
Deputy Chief Science and Medical Officer American Heart Association
Kathleen Warner, J.D.
Chief of Emerging Strategies and Ventures American Heart Association